Diclofenac Epolamine System
Product Images NDC 85534-0034

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 85534-0034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure of Diclofenac and Epolamine (2-(pyrrolidin-1-yl)ethanol) shown side by side. Diclofenac structure includes two chlorine atoms, amine group, and carboxylate group, while Epolamine is depicted with a nitrogen-containing ring and an ethanol side chain.*

FDA Label Image

Figure 1 (Diclofenac 02)

A line chart comparing the percent of patients improved against percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two data series with Diclofenac Patch indicated by filled circles and placebo by open squares, illustrating that a higher percentage of patients improved with the Diclofenac Patch across various improvement percentages.*

FDA Label Image

Figure 2 (Diclofenac 03)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and Placebo. The graph shows two curves, with Diclofenac Patch consistently showing higher patient improvement percentages than Placebo across the range of baseline improvements.*

FDA Label Image

Figure 3 (Diclofenac 04)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two curves, with Diclofenac Patch consistently having a higher percent of patients improved across increasing percent improvement levels compared to placebo.*

FDA Label Image

Figure 4 (Diclofenac 05)

A line graph comparing the percent improvement from baseline to the percent of patients improved for Diclofenac Patch versus placebo. The x-axis shows percent improvement from baseline, and the y-axis shows the percent of patients improved. The graph includes two lines: one for Diclofenac Patch and one for placebo, illustrating higher patient improvement rates for Diclofenac Patch across the range.*

FDA Label Image

1 (Label)

Label for Diclofenac Epolamine topical system 1.3% by Hawaii Repack, Inc. The label includes product NDC 85534-0034-0, a quantity of 30 dosage units, distributor information (Yaral Pharma, Inc.), storage instructions to keep at 20-25°C, and a caution that federal law prohibits dispensing without prescription. The label also contains a barcode and address for Hawaii Repack in Honolulu, HI.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.